These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23030476)

  • 21. Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis.
    Zhang S; Zhang F; Du M; Huang K; Wang C
    Br J Nutr; 2019 Apr; 121(8):841-848. PubMed ID: 30782220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
    Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
    Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron deficiency in heart failure: Efficacy and safety of intravenous iron therapy.
    Kang CK; Pope M; Lang CC; Kalra PR
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28836730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials.
    Mei Z; Chen J; Luo S; Jin L; Liu Q; Chen Y
    Pharmacol Res; 2022 Aug; 182():106345. PubMed ID: 35810949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Iron deficiency : a new target in treating chronic heart failure ?].
    Borgeaud M; Perrier A
    Rev Med Suisse; 2016 Oct; 12(535):1747-1751. PubMed ID: 28692214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Iron Deficiency in Heart Failure.
    Zusman O; Itzhaki Ben Zadok O; Gafter-Gvili A
    Acta Haematol; 2019; 142(1):51-56. PubMed ID: 30970349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
    Toblli JE; Di Gennaro F; Rivas C
    Heart Lung Circ; 2015 Jul; 24(7):686-95. PubMed ID: 25666998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.
    Anand IS; Gupta P
    Circulation; 2018 Jul; 138(1):80-98. PubMed ID: 29967232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need?
    Beavers CJ; Alburikan KA; Rodgers JE; Dunn SP; Reed BN
    Pharmacotherapy; 2014 Jul; 34(7):719-32. PubMed ID: 24676642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Scherhag A; Schwartz D
    Kidney Blood Press Res; 2005; 28(1):41-7. PubMed ID: 15489560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
    J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
    Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A
    Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.
    Terrovitis JV; Kaldara E; Ntalianis A; Sventzouri S; Kapelios C; Barbarousi D; Matsouka C; Nanas JN
    J Am Coll Cardiol; 2012 Nov; 60(21):2255-6. PubMed ID: 23103041
    [No Abstract]   [Full Text] [Related]  

  • 35. Anemia in heart failure: should we supplement iron in patients with chronic heart failure?
    Kaldara-Papatheodorou EE; Terrovitis JV; Nanas JN
    Pol Arch Med Wewn; 2010 Sep; 120(9):354-60. PubMed ID: 20864909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis.
    Dalal J; Katekhaye V; Jain R
    Indian Heart J; 2017; 69(6):736-741. PubMed ID: 29174251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
    Jankowska EA; Tkaczyszyn M; Suchocki T; Drozd M; von Haehling S; Doehner W; Banasiak W; Filippatos G; Anker SD; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):786-95. PubMed ID: 26821594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
    Beck-da-Silva L; Piardi D; Soder S; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
    Int J Cardiol; 2013 Oct; 168(4):3439-42. PubMed ID: 23680589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron deficiency: an emerging therapeutic target in heart failure.
    Cohen-Solal A; Leclercq C; Deray G; Lasocki S; Zambrowski JJ; Mebazaa A; de Groote P; Damy T; Galinier M
    Heart; 2014 Sep; 100(18):1414-20. PubMed ID: 24957529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.